Yatharth Hospital & Trauma Care Services financials

Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹393cr+52.3% on Q1 FY26
Net profit
₹45.4cr+8.0% on Q1 FY26
EBITDA margin
23.4%−1.7 pts on Q1 FY26
EPS
₹4.88+11.9% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue393258+52.3%
EBITDA91.764.5+42.2%
EBITDA margin23.4%25.0%−1.7 pts
Profit before tax61.258.7+4.3%
Net profit45.442.0+8.0%
EPS₹4.88₹4.36+11.9%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹393 crNet profit₹45.4 crNet margin11.6%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
9,110————
22122143611337.4
——31.72.92.0
2532530.083.1264
9,143————
1,3341,207880671372
—+37.1%+31.3%+80.5%—
310292220180105
23.3%24.2%25.0%26.8%28.4%
20920416315192.7
17417013111464.2
13.1%14.1%14.8%17.1%17.3%
₹18.11₹17.67₹13.55₹11.88₹6.66
—+30.5%+14.0%+78.4%—
—205150−3.163.8
—−317−311−93.4−19.8
−112−112−161−96.444.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

YATHARTH₹945.50

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHMEDANTAFORTISVIYASHTHYROCARESUPRIYASTARSPARCMcap ₹9,110 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————9,110.3
- Cash, Equiv & ST Investments37.4112.7435.9221.1221.1
+ Minority Interest2.02.931.7——
+ Total Debt263.883.10.0253.3253.3
Enterprise Value————9,142.5
Revenue371.5670.5880.51,207.21,334.1
Growth %, YoY—+80.5+31.3+37.1—
EBITDA105.3179.9220.2292.1310.4
Margin %28.3526.8325.0124.2023.26
EBIT92.7150.6163.1204.3209.2
Net Income64.2114.5130.6170.3174.5
Margin %17.2717.0714.8314.1113.08
EPS, Adj (current shares)6.6611.8813.5517.6718.11
Growth %, YoY—+78.4+14.0+30.5—
Cash from Operations63.8-3.1149.6204.5—
Capital Expenditures-19.8-93.4-310.8-316.5—
Free Cash Flow44.0-96.4-161.2-112.0-112.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Yatharth Hospital & Trauma Care Services financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) had a market capitalisation of ₹8,896 crore at the 29 October 2026 close (₹923.30 a share), a PE ratio of 49.9 on the last four quarters' profit and a price-to-book ratio of 4.92. In FY26 its consolidated net profit attributable to shareholders was ₹170 crore on revenue of ₹1,207 crore; in Q1 FY27 (April–June 2026) it was ₹47.1 crore, up 12.0% year on year. Its debt-to-equity ratio was 0.14 on 31 March 2026. Promoters held 55.80% of the shares on 30 September 2026.

Share price used
₹923.30 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Yatharth Hospital & Trauma Care Services at a glance · consolidated

Market cap
₹8,896 Crat ₹923.30 · 29 Oct close
PE ratio (last 4 quarters)
49.952.2 on FY26 profit
Price to book (PB)
4.92book value ₹187.55 a share
ROE (FY26)
10.0%−0.5 pts vs FY25ROCE 10.9%
Debt to equity
0.14net cash ₹10 Cr
Promoter holding
55.80%unchanged vs 30 Jun 202630 September 2026
Dividend yield
0.05%₹0.50 a share in 12 months
Net worth
₹1,807 Cr+12.6% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
−₹112 Cr

Questions

What is the Yatharth Hospital & Trauma Care Services PE ratio today?

Yatharth Hospital & Trauma Care Services' PE ratio is 49.9 at the 29 October 2026 close (₹923.30 a share): a market capitalisation of ₹8,896 crore divided by consolidated net profit attributable to shareholders of ₹178 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹170 crore) it is 52.2.

What is the Yatharth Hospital & Trauma Care Services PB ratio (price to book value)?

Yatharth Hospital & Trauma Care Services' price-to-book (PB) ratio is 4.92 at the 29 October 2026 close: a market capitalisation of ₹8,896 crore divided by shareholders' equity (book value) of ₹1,807 crore on 31 March 2026. That is a book value of ₹187.55 per share against a share price of ₹923.30.

What is the Yatharth Hospital & Trauma Care Services net worth?

Yatharth Hospital & Trauma Care Services' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,807 crore on 31 March 2026, up 12.6% from ₹1,605 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,896 crore at the 29 October 2026 close.

What is the Yatharth Hospital & Trauma Care Services market cap?

Yatharth Hospital & Trauma Care Services' market capitalisation was ₹8,896 crore at the 29 October 2026 close: 9.64 crore shares at ₹923.30 each.

What is the Yatharth Hospital & Trauma Care Services debt to equity ratio?

Yatharth Hospital & Trauma Care Services' debt-to-equity ratio was 0.14 on 31 March 2026: borrowings of ₹253 crore against total equity of ₹1,807 crore. A year earlier, on 31 March 2025, it was 0.00.

What is the Yatharth Hospital & Trauma Care Services dividend in 2026 and its record date?

In 2026, Yatharth Hospital & Trauma Care Services has declared one dividend: ₹0.50 (interim) with record date 14 August 2026.

Is Yatharth Hospital & Trauma Care Services debt free?

No. Yatharth Hospital & Trauma Care Services had borrowings of ₹253 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.14. Its cash and current investments were ₹263 crore, so it held net cash of ₹10 crore.

What is the Yatharth Hospital & Trauma Care Services book value per share?

Yatharth Hospital & Trauma Care Services' book value per share was ₹187.55 on 31 March 2026: shareholders' equity of ₹1,807 crore divided by the 9.64 crore shares in issue, up 12.6% from ₹166.62 a year earlier. The share price at the 29 October 2026 close was ₹923.30.

What is the Yatharth Hospital & Trauma Care Services dividend yield?

Yatharth Hospital & Trauma Care Services' dividend yield is 0.05% at the 29 October 2026 close: dividends of ₹0.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹923.30. They were ₹0.50 on 14 August 2026 (interim).

What is the Yatharth Hospital & Trauma Care Services ROE and ROCE?

In FY26, Yatharth Hospital & Trauma Care Services' return on equity (ROE) was 10.0% and its return on capital employed (ROCE) was 10.9%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 10.5% and ROCE 12.6%.

What is the Yatharth Hospital & Trauma Care Services shareholding pattern?

On 30 September 2026, Yatharth Hospital & Trauma Care Services' shares were held by promoters 55.80%, foreign portfolio investors (FII/FPI) 7.05%, domestic institutions (DII) 10.94% (including mutual funds at 9.56%) and retail and other non-institutional investors 26.21%. Over the year, FII holding was up 0.55 percentage points from 6.50% and DII holding was up 2.24 percentage points from 8.70%.

What are the Yatharth Hospital & Trauma Care Services latest quarterly results?

Yatharth Hospital & Trauma Care Services' latest results are for Q1 FY27 (April–June 2026), filed on 10 August 2026: consolidated net profit attributable to shareholders ₹47.1 crore, up 12.0% from ₹42 crore in Q1 FY26; revenue from operations ₹393 crore, up 52.3% year on year.

What is the Yatharth Hospital & Trauma Care Services EPS?

Yatharth Hospital & Trauma Care Services' basic earnings per share (EPS) were ₹18.20 in FY26, against ₹14.72 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹18.80.

What is the Yatharth Hospital & Trauma Care Services promoter holding?

Promoters held 55.80% of Yatharth Hospital & Trauma Care Services on 30 September 2026, unchanged from the previous quarter and down 5.84 percentage points from 61.64% a year earlier, according to the shareholding pattern filed with NSE.

When are the Yatharth Hospital & Trauma Care Services next results?

Yatharth Hospital & Trauma Care Services will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.

What is the Yatharth Hospital & Trauma Care Services free cash flow?

In FY26, Yatharth Hospital & Trauma Care Services generated ₹205 crore of cash from operations and spent ₹317 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹112 crore. In FY25 it was −₹161 crore.

What is the Yatharth Hospital & Trauma Care Services revenue and profit in FY26?

In FY26 (April 2025–March 2026), Yatharth Hospital & Trauma Care Services' consolidated net profit attributable to shareholders was ₹170 crore, up 30.5% from ₹131 crore in FY25, on revenue from operations of ₹1,207 crore (up 37.1%). Over three years, from FY23, net profit was up 165.4%.

How does the Yatharth Hospital & Trauma Care Services PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Yatharth Hospital & Trauma Care Services' PE ratio is 52.2, the lowest of the four: Max Healthcare Institute 57.4, Global Health 62.8 and Fortis Healthcare 54.7, a peer average of 58.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.

How does Yatharth Hospital & Trauma Care Services compare with its peers?

On FY26 consolidated figures, against Max Healthcare Institute, Global Health and Fortis Healthcare: Yatharth Hospital & Trauma Care Services' operating margin of 16.9% is the third highest of the four (Max Healthcare Institute 21.5%, Global Health 15.8%, Fortis Healthcare 17.9%; peer average 18.4%); its return on equity of 10.0% is the lowest of the four (Max Healthcare Institute 14.3%, Global Health 15.2%, Fortis Healthcare 11.1%; peer average 13.5%); its revenue growth over three years of 48.1% a year is the highest of the four (Max Healthcare Institute 22.4% a year, Global Health 17.9% a year, Fortis Healthcare 13.2% a year; peer average 17.8% a year).

Yatharth Hospital & Trauma Care Services vs Max Healthcare Institute: how do they compare?

In FY26, Yatharth Hospital & Trauma Care Services earned net profit attributable to shareholders of ₹170 crore on revenue of ₹1,207 crore, against ₹1,442 crore on ₹8,373 crore for Max Healthcare Institute. Yatharth Hospital & Trauma Care Services' operating margin was 16.9% (Max Healthcare Institute 21.5%) and its return on equity 10.0% (Max Healthcare Institute 14.3%). At the 29 October 2026 close, Yatharth Hospital & Trauma Care Services' market capitalisation was ₹8,896 crore against ₹82,837 crore for Max Healthcare Institute, and its PE ratio on FY26 profit 52.2 against 57.4.

Where do these Yatharth Hospital & Trauma Care Services figures come from?

From Yatharth Hospital & Trauma Care Services' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.